Literature DB >> 10487825

DNA copy number losses in human neoplasms.

S Knuutila1, Y Aalto, K Autio, A M Björkqvist, W El-Rifai, S Hemmer, T Huhta, E Kettunen, S Kiuru-Kuhlefelt, M L Larramendy, T Lushnikova, O Monni, H Pere, J Tapper, M Tarkkanen, A Varis, V M Wasenius, M Wolf, Y Zhu.   

Abstract

This review summarizes reports of recurrent DNA sequence copy number losses in human neoplasms detected by comparative genomic hybridization. Recurrent losses that affect each of the chromosome arms in 73 tumor types are tabulated from 169 reports. The tables are available online at http://www.amjpathol.org and http://www. helsinki.fi/ approximately lglvwww/CMG.html. The genes relevant to the lost regions are discussed for each of the chromosomes. The review is supplemented also by a list of known and putative tumor suppressor genes and DNA repair genes (see Table 1, online). Losses are found in all chromosome arms, but they seem to be relatively rare at 1q, 2p, 3q, 5p, 6p, 7p, 7q, 8q, 12p, and 20q. Losses and their minimal common overlapping areas that were present in a great proportion of the 73 tumor entities reported in Table 2 (see online) are (in descending order of frequency): 9p23-p24 (48%), 13q21 (47%), 6q16 (44%), 6q26-q27 (44%), 8p23 (37%), 18q22-q23 (37%), 17p12-p13 (34%), 1p36.1 (34%), 11q23 (33%), 1p22 (32%), 4q32-qter (31%), 14q22-q23 (25%), 10q23 (25%), 10q25-qter (25%),15q21 (23%), 16q22 (23%), 5q21 (23%), 3p12-p14 (22%), 22q12 (22%), Xp21 (21%), Xq21 (21%), and 10p12 (20%). The frequency of losses at chromosomes 7 and 20 was less than 10% in all tumors. The chromosomal regions in which the most frequent losses are found implicate locations of essential tumor suppressor genes and DNA repair genes that may be involved in the pathogenesis of several tumor types.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487825      PMCID: PMC1866903          DOI: 10.1016/S0002-9440(10)65166-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  191 in total

1.  Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas.

Authors:  J Herbers; D Schullerus; H Müller; C Kenck; J Chudek; J Weimer; P Bugert; G Kovacs
Journal:  Genes Chromosomes Cancer       Date:  1997-05       Impact factor: 5.006

2.  Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.

Authors:  D W Bell; S C Jhanwar; J R Testa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

3.  FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

Authors:  K M Fong; E J Biesterveld; A Virmani; I Wistuba; Y Sekido; S A Bader; M Ahmadian; S T Ong; F V Rassool; P V Zimmerman; G Giaccone; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

4.  Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.

Authors:  S Zhou; P Buckhaults; L Zawel; F Bunz; G Riggins; J L Dai; S E Kern; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT).

Authors:  I van Bakel; T Sepp; S Ward; J R Yates; A J Green
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

6.  Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

Authors:  E Rhei; L Kang; F Bogomolniy; M G Federici; P I Borgen; J Boyd
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

7.  Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.

Authors:  A M Voesten; E H Bijleveld; A Westerveld; T J Hulsebos
Journal:  Genes Chromosomes Cancer       Date:  1997-10       Impact factor: 5.006

8.  Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.

Authors:  D E Schofield; J B Beckwith; J Sklar
Journal:  Genes Chromosomes Cancer       Date:  1996-01       Impact factor: 5.006

9.  Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.

Authors:  K Suzuki; T Ogura; T Yokose; K Nagai; K Mukai; T Kodama; Y Nishiwaki; H Esumi
Journal:  Int J Cancer       Date:  1998-08-21       Impact factor: 7.396

10.  Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.

Authors:  X Gao; K V Honn; D Grignon; W Sakr; Y Q Chen
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

View more
  88 in total

1.  Online access to CGH data of DNA sequence copy number changes.

Authors:  S Knuutila; K Autio; Y Aalto
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p.

Authors:  Z Adám; R Adány; A Ladányi; J Tímár; M Balázs
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Digital karyotyping.

Authors:  Tian-Li Wang; Christine Maierhofer; Michael R Speicher; Christoph Lengauer; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

4.  A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization.

Authors:  Yeun-Jun Chung; Jos Jonkers; Hannah Kitson; Heike Fiegler; Sean Humphray; Carol Scott; Sarah Hunt; Yuejin Yu; Ichiko Nishijima; Arno Velds; Henne Holstege; Nigel Carter; Allan Bradley
Journal:  Genome Res       Date:  2004-01       Impact factor: 9.043

5.  NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Authors:  Tsutomu Mori; Daisuke D Ikeda; Toshihiko Fukushima; Seiichi Takenoshita; Hideo Kochi
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

6.  DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer.

Authors:  W El-Rifai; D Kamel; M L Larramendy; S Shoman; Y Gad; S Baithun; M El-Awady; S Eissa; H Khaled; S Soloneski; M Sheaff; S Knuutila
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

7.  Molecular cytogenetics of mouse models of breast cancer.

Authors:  Thomas Ried; Kathy Dorritie; Zoë Weaver; Danny Wangsa; Michael J Difilippantonio; Cristina Montagna
Journal:  Breast Dis       Date:  2004

Review 8.  Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

Authors:  Mu-Shui Dai; Yetao Jin; Jayme R Gallegos; Hua Lu
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

9.  Comparative genomic hybridisation as a supportive tool in diagnostic pathology.

Authors:  M M Weiss; E J Kuipers; S G M Meuwissen; P J van Diest; G A Meijer
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 10.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.